Declaration of Helsinki Addresses New Ethical Challenges
Release Date: 10/19/2024
JAMA Author Interviews
Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of...
info_outlineJAMA Author Interviews
Interview with Sameer Jauhar, PhD, author of Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content:
info_outlineJAMA Author Interviews
Interview with Dennis J. Rivet II, MD, author of GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. Hosted by Cynthia E. Armand, MD. Related Content:
info_outlineJAMA Author Interviews
Nationwide data are unavailable regarding changes in intensive care unit (ICU) outcomes over the past 10 years, limiting understanding of practice changes. Authors Emily Moin, MD, MBE, and Scott D. Halpern, MD, PhD, MBE, of the University...
info_outlineJAMA Author Interviews
The incidence of invasive group A streptococcal infections has risen in the US. Similar observations have been reported in other parts of the world. Authors Joshua Osowicki, MBBS, PhD, of Murdoch Children’s Research Institute and Theresa...
info_outlineJAMA Author Interviews
Less than 20% of patients eligible for lung cancer screening get screened in the US. A recent study examined whether adults eligible for lung cancer screening engage in screening for other types of cancer. Coauthor Chi-Fu Jeffrey Yang,...
info_outlineJAMA Author Interviews
Despite increased participation in US long-distance running races, cardiac arrest incidence remains stable. Authors Jonathan Kim, MD, MSc, of Emory University, and Aaron Baggish, MD, of the University of Lausanne Switzerland, discuss the...
info_outlineJAMA Author Interviews
ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor...
info_outlineJAMA Author Interviews
The US Food and Drug Administration (FDA) issued new draft regulatory guidance for pulse oximeters related to skin pigment. The guidance is a step forward but it may have unintended consequences. Authors Michael Lipnick, MD, and Philip...
info_outlineJAMA Author Interviews
The CAUGHT-CAD randomized clinical trial sought to determine whether a CAC score-informed strategy could slow the progression of coronary plaque volume. Author Thomas H. Marwick of the Baker Heart & Diabetes Institute joins JAMA...
info_outlineThe Declaration of Helsinki originated in 1964, developed by the World Medical Association (WMA). Process Chair Jack S. Resneck Jr, MD, discusses the 2024 updates to the Declaration of Helsinki with JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.
Related Content:
- Revisions to the Declaration of Helsinki on Its 60th Anniversary
- World Medical Association Declaration of Helsinki
- Making the Ethical Oversight of All Clinical Trials Fit for Purpose
- The Revised Declaration of Helsinki—Considerations for the Future of Artificial Intelligence in Health and Medical Research
- Revisiting the Declaration of Helsinki—A Patient-Centered Perspective
- Future-Proofing Research Ethics—Key Revisions of the Declaration of Helsinki 2024
- The Revision of the Declaration of Helsinki Viewed From the Americas—Paving the Way to Better Research
- Declaration of Helsinki—Revisions for the 21st Century
- Facilitating Efficient and Ethical Trials at the Intersection of Research and Clinical Care
- The 2024 Revision to the Declaration of Helsinki